Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder

NACompletedINTERVENTIONAL
Enrollment

692

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions
Overactive Bladder
Interventions
BEHAVIORAL

Health education intervention (HEI)

"* \<Part 1\> Understanding OAB~* \<Part 2\> Behavioral/lifestyle modification~* \<Part 3\> Bladder training~* \<Part 4\> Understanding antimuscarinics"

Trial Locations (13)

420-717

Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon-si

420-767

Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon-si

630-522

Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon

705-034

Daegu Catholic University College of Medicine, Daegu

301-721

Chungnam National University Hospital, Daejeon

501-757

Chonnam National University Medical School, Gwangju

602-739

Pusan National University Hospital, Pusan

100-380

Cheil General Hospital & Women's Healthcare Center, College of Medicine, Kwandong University, Seoul

110-744

Seoul National University Hospital, Seoul

120-752

Yonsei University College of Medicine, Seoul

135-710

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul

136-705

Anam Hospital, College of Medicine, Korea University, Seoul

138-736

Asan Medical Center, Ulsan University College of Medicine, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Samsung Medical Center

OTHER